Sign In
Buy ILMN
$168.06
-2.87 (-1.68%)
At Close: Jun 04, 2026
GRAIL to Present Final Multi-cancer Early Detection Data From the Interventional PATHFINDER Study at ESMO Congress 2022
06:05pm, Thursday, 08'th Sep 2022
MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL announced final results from the interventional PATHFINDER study will be presented at the European Society for Medical Oncology Congress 2022
SAN DIEGO , Sept. 8, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that investors, analysts, and other interested parties may view a live webcast of the Innovation Roadmap session
Illumina to appeal after European Commission prohibits $7.1 billion GRAIL acquisition
05:24pm, Tuesday, 06'th Sep 2022
Illumina announced Tuesday it plans to appeal the European Commission's decision to prohibit the company's acquisition of cancer detection company GRAIL.
Exclusive-Illumina in talks with EU regulators to divest Grail - sources
09:43am, Monday, 05'th Sep 2022
BRUSSELS (Reuters) -U.S. life sciences company Illumina is in talks with European Union antitrust regulators to divest Grail ahead of an expected EU veto next week of its $7.1 billion acquisition of t
FTC appeals ruling in case challenging Illumina's acquisition of GRAIL
06:48pm, Friday, 02'nd Sep 2022
The Federal Trade Commission on Friday filed a notice of appeal in its case challenging Illumina's $7.1 billion acquisition of cancer detection company GRAIL.
FTC to appeal judge's decision on Illumina-Grail deal
03:16pm, Friday, 02'nd Sep 2022
WASHINGTON (Reuters) -The Federal Trade Commission on Friday said it will appeal an administrative judge's decision earlier this week in favor of Illumina Inc's acquisition of cancer detection test ma
Illumina (ILMN) Stock Rises After Its Win Against the FTC
02:45pm, Friday, 02'nd Sep 2022
Source: Connect world / Shutterstock.com Genetic-sequence product specialist Illumina (NASDAQ: ILMN ) lit up business headlines on Thursday evening after the company secured a legal victory in an anti
Is Illumina a Buy?
10:53am, Friday, 02'nd Sep 2022
Illumina's top line is going to be under more pressure in the short term as well as in the medium term.
Got $10,000? Consider Buying the Dip on This Monster Growth Stock
09:20am, Friday, 02'nd Sep 2022
Illumina is having a bumpy ride, but it's playing the long game.
Illumina wins FTC GRAIL case in $7.1 billion deal
05:05pm, Thursday, 01'st Sep 2022
Illumina said Thursday it has won in the Federal Trade Commission's case challenging its $7.1 billion acquisition of cancer detection company GRAIL.
FTC Challenge of Illumina's Acquisition of Grail Rejected by Judge
02:19pm, Thursday, 01'st Sep 2022
An administrative law judge rejects the Federal Trade Commission's challenge of Illumina's acquisition last year of Grail.
Illumina defeats F.T.C. in major antitrust case.
02:15pm, Thursday, 01'st Sep 2022
The case was seen as a test of a more aggressive policy by the agency.
Illumina wins case against U.S. FTC on Grail purchase - WSJ
12:28pm, Thursday, 01'st Sep 2022
A judge has ruled in favor of Illumina Inc in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade Commission's efforts to unwind the multi-billion-dollar deal, the Wall Street Journa
Here is What to Know Beyond Why Illumina, Inc. (ILMN) is a Trending Stock
10:03am, Thursday, 01'st Sep 2022
Illumina (ILMN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Final Trades: CVS, Hershey, Illumina & more
02:11pm, Wednesday, 31'st Aug 2022
The "Halftime Report" traders give their top picks to watch for the second half.
